Generation bio outlines 2022 strategic priorities and reports fourth quarter and full year 2021 financial results

Well-capitalized with $375.1 million at the end of 2021, funding planned operations into 2024 well-capitalized with $375.1 million at the end of 2021, funding planned operations into 2024

GBIO Ratings Summary

GBIO Quant Ranking